Segall Bryant & Hamill LLC bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 36,987 shares of the company’s stock, valued at approximately $297,000. Segall Bryant & Hamill LLC owned approximately 0.09% of Viemed Healthcare as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the stock. Barclays PLC increased its position in shares of Viemed Healthcare by 342.3% during the third quarter. Barclays PLC now owns 53,439 shares of the company’s stock worth $392,000 after acquiring an additional 41,358 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Viemed Healthcare by 151.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company’s stock worth $724,000 after purchasing an additional 59,538 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Viemed Healthcare by 748.2% in the 3rd quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock valued at $795,000 after purchasing an additional 95,706 shares during the period. SG Americas Securities LLC lifted its holdings in shares of Viemed Healthcare by 193.1% in the fourth quarter. SG Americas Securities LLC now owns 35,579 shares of the company’s stock valued at $285,000 after purchasing an additional 23,442 shares in the last quarter. Finally, Wasatch Advisors LP boosted its position in shares of Viemed Healthcare by 19.6% during the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock worth $13,552,000 after buying an additional 303,277 shares during the period. 74.24% of the stock is currently owned by institutional investors and hedge funds.
Viemed Healthcare Stock Up 0.3 %
NASDAQ:VMD opened at $7.27 on Friday. The company has a market cap of $287.32 million, a PE ratio of 26.93 and a beta of 1.50. The stock has a 50-day simple moving average of $7.82 and a 200 day simple moving average of $8.18. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a 52-week low of $6.21 and a 52-week high of $9.81.
Viemed Healthcare Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
See Also
- Five stocks we like better than Viemed Healthcare
- Where Do I Find 52-Week Highs and Lows?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What Makes a Stock a Good Dividend Stock?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.